TH67134B - Pyrrolol compounds [2,3-d] pyridine - Google Patents
Pyrrolol compounds [2,3-d] pyridineInfo
- Publication number
- TH67134B TH67134B TH1004768A TH0001004768A TH67134B TH 67134 B TH67134 B TH 67134B TH 1004768 A TH1004768 A TH 1004768A TH 0001004768 A TH0001004768 A TH 0001004768A TH 67134 B TH67134 B TH 67134B
- Authority
- TH
- Thailand
- Prior art keywords
- diabetic
- disease
- traumatic
- pyrrolol
- pyridine
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
- WLODWTPNUWYZKN-UHFFFAOYSA-N 1h-pyrrol-2-ol Chemical class OC1=CC=CN1 WLODWTPNUWYZKN-UHFFFAOYSA-N 0.000 title 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
- 201000004624 Dermatitis Diseases 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 230000000472 traumatic effect Effects 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010017711 Gangrene Diseases 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 206010040882 skin lesion Diseases 0.000 abstract 1
- 231100000444 skin lesion Toxicity 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Abstract
DC60 (12/01/44) สารประกอบสูตร (สูครเคมี) I ที่ซึ่ง R1 , R2 และ R3 เป็นไปตามที่นิยามข้างต้น, ซึ่งเป็นสารยับยั้งเอ็นไซม์โปรตีนคิเนส เช่น จานัสคิเบส 3 และในรูปเช่นนี้ เป็นประโยชน์ในการรักษา ในฐานะสารป้องกันหรือลดผลิตผลภูมิคุ้มกันสำหรับการ ย้ายปะตอนอวัยวะ , การย้ายปะตอนเนื้อเยื่อซีโน , กลุ่มของ โรคผิวหนังที่มีบาดแผลหรือรอยแผล , การกระด้างหลายแห่ง , ข้ออักเสบรูมาตอยด์ , ขี้เรื้อนกวาง , ไดอะบีทิส ชนิด I และ โรคแทรกซ้อนจาก ไดอะบีทิส , มะเร็ง , หืด , ผิวหนังอักเสบ จากภูมิแพ้ , ความผิดปกติของออโตอิมมูนไธรอยด์ , ลำไส้ ใหญ่อักเสบที่เป็นแผลเปื่อย , โรค Crohn , โรค Alzheimer , ลิวคีเมีย และโรคออโตอิมมูนอื่น. สิทธิบัตรยา DC60 (12/01/44) Compound formula (chemical formula) I where R1, R2 and R3 meet the above definition, which are inhibitors of protein kinase enzymes such as Janaskibase 3. And in a picture like this It is useful in treatment As a protective or reducing agent Epidural gangrene, Xino tissue implantation, traumatic or traumatic dermatitis, multiple skin lesions, rheumatoid arthritis, eczema, type I diabetic and complications from Diabetic, cancer, asthma, atopic dermatitis, autoimmune disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autism. Another moon. Drug patent
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH52660A TH52660A (en) | 2002-08-26 |
| TH67134B true TH67134B (en) | 2018-12-25 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2382404A1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
| BR0016263A (en) | Pyrrolo [2,3-d] pyrimidine compounds | |
| WO2002009713A3 (en) | Selective pde 2 inhibitors, used as medicaments for improving cognition | |
| WO2004026867A3 (en) | Imidazopyridines as cyclin dependent kinase inhibitors | |
| MY139336A (en) | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
| MY137843A (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| PA8476001A1 (en) | PIRROLO COMPOUNDS [2,3-d) PYRIMIDINE | |
| WO2003039540A3 (en) | D-amino acid oxidase inhibitors for learning and memory | |
| PL319042A1 (en) | Pyrimido [5,4-d] pyrimidines, pharmaceutic agents containing such compounds, their application and drugs containing them | |
| TW200420564A (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| HU9601412D0 (en) | Isoxazoline compounds as antiinflammatory agents | |
| WO2004005281A8 (en) | Inhibitors of tyrosine kinases | |
| MY148652A (en) | New crystalline form of a triazolo(4,5-d)pyrimidine compound | |
| PT1539783E (en) | Inhibitors of nucleoside phosphorylases and nucleosidases | |
| TNSN01095A1 (en) | NOVEL PYRROLO [2,3-d] PYRIMIDINE DERIVATIVES AND COMPOSITIONS CONTAINING THEM | |
| DE69816608D1 (en) | 1H-PYRAZOLO [3,4-D] PYRIMIDINE-4,6-DIONE AS INHIBITORS FOR T-CELL REPRODUCTION | |
| MXPA04003668A (en) | Type 4 phosphodiesterase inhibitors and uses thereof. | |
| WO2003041643A3 (en) | Hsp90-inhibiting zearalanol compounds and methods of producing and using same | |
| WO2001096298A3 (en) | 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase | |
| GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
| MY136840A (en) | Pyrazolopyridines as cyclin dependent kinase inhibitors | |
| WO2002014281A8 (en) | Pyridine derivatives as inhibitors of p38 | |
| WO1999012933A3 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase | |
| WO2002059084A3 (en) | Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof |